Why the study?
Does DDIR pacing reduce the development of chronic atrial fibrillation and complications compared to VVIR pacing in patients with paroxysmal atrial tachyarrhythmias?
Does DDIR pacing reduce the development of chronic atrial fibrillation and complications compared to VVIR pacing in patients with paroxysmal atrial tachyarrhythmias?
In patients with paroxysmal atrial tachyarrhythmias, DDIR pacing may be associated with fewer complications than VVIR pacing, though it requires more intensive management and antiarrhythmic medication.
Answers are grounded in this paper and cite their sources.
DDIR pacing was associated with fewer symptoms and complications than VVIR; leaves open effect on chronic AF and warrants randomized trials.
Patients with sinus node dysfunction (SND) in particular those with tachycardia-bradycardia syndrome and patients undergoing atrioventricular nodal ablation procedures for refractory paroxysmal atrial tachyarrhythmias (PAT), are candidates for single chamber (VVIR mode) or dual chamber rate responsive (DDIR mode) systems. To evaluate the benefits and disadvantages of each pacing mode we retrospectively analyzed 33 patients with a history of frequent PAT who received a VVIR (22 patients); or a DDDR pacemaker (11 patients) programmed to the DDIR mode. The mean follow-up time was 25 and 18 months, respectively. Preimplant left atrial diameter was significantly smaller in the DDIR group. Chronic atrial fibrillation developed in 54% of the VVIR patients and 27% of the DDIR group, but this difference was not significant. Complications of patients with VVIR pacemakers included new mitral and tricuspid insufficiency, stroke, pacemaker intolerance and aggravated congestive heart failure. Patients with DDIR pacemakers had a lower incidence of symptoms and complications. However, this group received more antiarrhythmic medication, required a closer follow-up, and their pacemakers needed frequent reprogramming. Our findings suggest that VVIR is a poor choice for patients with SND, congestive heart failure, and PAT, and that DDIR may be an acceptable alternative.
No takes yet. Share an insight, caveat, or question.
Vanerio et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: